nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1D—cochlea—head and neck cancer	0.0565	0.204	CbGeAlD
Isradipine—CACNA1D—internal ear—head and neck cancer	0.0535	0.193	CbGeAlD
Isradipine—CACNA1D—ear—head and neck cancer	0.0361	0.13	CbGeAlD
Isradipine—Digestion impaired—Hydroxyurea—head and neck cancer	0.0192	0.0269	CcSEcCtD
Isradipine—CACNA2D2—neck—head and neck cancer	0.0191	0.0687	CbGeAlD
Isradipine—Numbness—Vinblastine—head and neck cancer	0.017	0.0238	CcSEcCtD
Isradipine—Sensory loss—Vinblastine—head and neck cancer	0.0163	0.0228	CcSEcCtD
Isradipine—Raised liver function tests—Docetaxel—head and neck cancer	0.0145	0.0203	CcSEcCtD
Isradipine—CACNA1S—thyroid gland—head and neck cancer	0.0116	0.0417	CbGeAlD
Isradipine—Tingling sensation—Fluorouracil—head and neck cancer	0.0115	0.0161	CcSEcCtD
Isradipine—Numbness—Fluorouracil—head and neck cancer	0.0112	0.0156	CcSEcCtD
Isradipine—Sensory loss—Fluorouracil—head and neck cancer	0.0107	0.015	CcSEcCtD
Isradipine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0104	0.0146	CcSEcCtD
Isradipine—Throat sore—Docetaxel—head and neck cancer	0.00927	0.013	CcSEcCtD
Isradipine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00919	0.0129	CcSEcCtD
Isradipine—CACNA2D2—thyroid gland—head and neck cancer	0.00907	0.0327	CbGeAlD
Isradipine—Dermatitis atopic—Docetaxel—head and neck cancer	0.00903	0.0126	CcSEcCtD
Isradipine—Angina pectoris—Vinblastine—head and neck cancer	0.00862	0.0121	CcSEcCtD
Isradipine—CACNA1C—connective tissue—head and neck cancer	0.00844	0.0304	CbGeAlD
Isradipine—Breast disorder—Hydroxyurea—head and neck cancer	0.00844	0.0118	CcSEcCtD
Isradipine—CACNA2D2—head—head and neck cancer	0.00805	0.029	CbGeAlD
Isradipine—Depression—Vinblastine—head and neck cancer	0.00787	0.011	CcSEcCtD
Isradipine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00778	0.0109	CcSEcCtD
Isradipine—Myocardial infarction—Vinblastine—head and neck cancer	0.00773	0.0108	CcSEcCtD
Isradipine—CACNA1H—thyroid gland—head and neck cancer	0.00736	0.0265	CbGeAlD
Isradipine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00735	0.0103	CcSEcCtD
Isradipine—Weight increased—Hydroxyurea—head and neck cancer	0.00734	0.0103	CcSEcCtD
Isradipine—Drowsiness—Hydroxyurea—head and neck cancer	0.0072	0.0101	CcSEcCtD
Isradipine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00705	0.00987	CcSEcCtD
Isradipine—CACNB2—thyroid gland—head and neck cancer	0.00695	0.0251	CbGeAlD
Isradipine—Cardiac failure—Fluorouracil—head and neck cancer	0.00689	0.00964	CcSEcCtD
Isradipine—Lethargy—Fluorouracil—head and neck cancer	0.00686	0.0096	CcSEcCtD
Isradipine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00681	0.00953	CcSEcCtD
Isradipine—CACNA2D1—thyroid gland—head and neck cancer	0.00652	0.0235	CbGeAlD
Isradipine—Fluid retention—Docetaxel—head and neck cancer	0.00634	0.00888	CcSEcCtD
Isradipine—CACNB2—head—head and neck cancer	0.00616	0.0222	CbGeAlD
Isradipine—CACNA1D—thyroid gland—head and neck cancer	0.00607	0.0219	CbGeAlD
Isradipine—Angiopathy—Hydroxyurea—head and neck cancer	0.00586	0.00821	CcSEcCtD
Isradipine—CACNA2D1—head—head and neck cancer	0.00579	0.0209	CbGeAlD
Isradipine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00572	0.00801	CcSEcCtD
Isradipine—Anaemia—Vinblastine—head and neck cancer	0.0057	0.00798	CcSEcCtD
Isradipine—Angina pectoris—Fluorouracil—head and neck cancer	0.00566	0.00792	CcSEcCtD
Isradipine—CACNA2D2—lymph node—head and neck cancer	0.00563	0.0203	CbGeAlD
Isradipine—Malaise—Vinblastine—head and neck cancer	0.00556	0.00779	CcSEcCtD
Isradipine—Leukopenia—Vinblastine—head and neck cancer	0.00552	0.00773	CcSEcCtD
Isradipine—CACNA1D—head—head and neck cancer	0.00539	0.0194	CbGeAlD
Isradipine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.0053	0.00742	CcSEcCtD
Isradipine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00522	0.00731	CcSEcCtD
Isradipine—Anaemia—Hydroxyurea—head and neck cancer	0.0052	0.00728	CcSEcCtD
Isradipine—Discomfort—Vinblastine—head and neck cancer	0.00519	0.00726	CcSEcCtD
Isradipine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00512	0.00717	CcSEcCtD
Isradipine—Visual disturbance—Docetaxel—head and neck cancer	0.00512	0.00717	CcSEcCtD
Isradipine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00511	0.00715	CcSEcCtD
Isradipine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00508	0.00711	CcSEcCtD
Isradipine—Malaise—Hydroxyurea—head and neck cancer	0.00507	0.0071	CcSEcCtD
Isradipine—Leukopenia—Hydroxyurea—head and neck cancer	0.00503	0.00705	CcSEcCtD
Isradipine—CACNA1C—head—head and neck cancer	0.00497	0.0179	CbGeAlD
Isradipine—Cardiac failure—Docetaxel—head and neck cancer	0.00497	0.00696	CcSEcCtD
Isradipine—Lethargy—Docetaxel—head and neck cancer	0.00495	0.00693	CcSEcCtD
Isradipine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00493	0.0069	CcSEcCtD
Isradipine—Pain in extremity—Docetaxel—head and neck cancer	0.00485	0.00679	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00475	0.00666	CcSEcCtD
Isradipine—Discomfort—Hydroxyurea—head and neck cancer	0.00473	0.00662	CcSEcCtD
Isradipine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00463	0.00648	CcSEcCtD
Isradipine—Oedema—Hydroxyurea—head and neck cancer	0.00459	0.00643	CcSEcCtD
Isradipine—CACNA1H—lymph node—head and neck cancer	0.00457	0.0165	CbGeAlD
Isradipine—Paraesthesia—Vinblastine—head and neck cancer	0.00452	0.00633	CcSEcCtD
Isradipine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0045	0.0063	CcSEcCtD
Isradipine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00449	0.00629	CcSEcCtD
Isradipine—Amlodipine—CYP1A1—head and neck cancer	0.00449	0.528	CrCbGaD
Isradipine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00448	0.00627	CcSEcCtD
Isradipine—Skin disorder—Hydroxyurea—head and neck cancer	0.00446	0.00624	CcSEcCtD
Isradipine—Breast disorder—Docetaxel—head and neck cancer	0.00438	0.00614	CcSEcCtD
Isradipine—Decreased appetite—Vinblastine—head and neck cancer	0.00437	0.00613	CcSEcCtD
Isradipine—Cramp muscle—Docetaxel—head and neck cancer	0.00437	0.00612	CcSEcCtD
Isradipine—CACNB2—lymph node—head and neck cancer	0.00432	0.0156	CbGeAlD
Isradipine—Constipation—Vinblastine—head and neck cancer	0.0043	0.00603	CcSEcCtD
Isradipine—Feeling abnormal—Vinblastine—head and neck cancer	0.00415	0.00581	CcSEcCtD
Isradipine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00409	0.00573	CcSEcCtD
Isradipine—Angina pectoris—Docetaxel—head and neck cancer	0.00408	0.00572	CcSEcCtD
Isradipine—Somnolence—Hydroxyurea—head and neck cancer	0.00408	0.00571	CcSEcCtD
Isradipine—CACNA2D1—lymph node—head and neck cancer	0.00405	0.0146	CbGeAlD
Isradipine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00404	0.00566	CcSEcCtD
Isradipine—Nifedipine—CYP1A1—head and neck cancer	0.00401	0.472	CrCbGaD
Isradipine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00399	0.00559	CcSEcCtD
Isradipine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00396	0.00555	CcSEcCtD
Isradipine—Fatigue—Hydroxyurea—head and neck cancer	0.00396	0.00554	CcSEcCtD
Isradipine—Constipation—Hydroxyurea—head and neck cancer	0.00392	0.00549	CcSEcCtD
Isradipine—Weight increased—Docetaxel—head and neck cancer	0.00382	0.00534	CcSEcCtD
Isradipine—Vision blurred—Fluorouracil—head and neck cancer	0.00381	0.00534	CcSEcCtD
Isradipine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00378	0.0053	CcSEcCtD
Isradipine—CACNA1D—lymph node—head and neck cancer	0.00377	0.0136	CbGeAlD
Isradipine—Anaemia—Fluorouracil—head and neck cancer	0.00374	0.00524	CcSEcCtD
Isradipine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00369	0.00516	CcSEcCtD
Isradipine—Myocardial infarction—Docetaxel—head and neck cancer	0.00366	0.00513	CcSEcCtD
Isradipine—Leukopenia—Fluorouracil—head and neck cancer	0.00362	0.00507	CcSEcCtD
Isradipine—Asthenia—Vinblastine—head and neck cancer	0.00361	0.00506	CcSEcCtD
Isradipine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00354	0.00495	CcSEcCtD
Isradipine—CACNA1C—lymph node—head and neck cancer	0.00348	0.0126	CbGeAlD
Isradipine—Chest pain—Fluorouracil—head and neck cancer	0.00345	0.00482	CcSEcCtD
Isradipine—Diarrhoea—Vinblastine—head and neck cancer	0.00344	0.00482	CcSEcCtD
Isradipine—Discomfort—Fluorouracil—head and neck cancer	0.0034	0.00477	CcSEcCtD
Isradipine—Hepatitis—Docetaxel—head and neck cancer	0.00336	0.0047	CcSEcCtD
Isradipine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00334	0.00468	CcSEcCtD
Isradipine—Dizziness—Vinblastine—head and neck cancer	0.00333	0.00466	CcSEcCtD
Isradipine—Urinary tract disorder—Docetaxel—head and neck cancer	0.00331	0.00464	CcSEcCtD
Isradipine—Oedema peripheral—Docetaxel—head and neck cancer	0.00331	0.00463	CcSEcCtD
Isradipine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0033	0.00463	CcSEcCtD
Isradipine—Oedema—Fluorouracil—head and neck cancer	0.0033	0.00463	CcSEcCtD
Isradipine—Connective tissue disorder—Docetaxel—head and neck cancer	0.0033	0.00462	CcSEcCtD
Isradipine—Asthenia—Hydroxyurea—head and neck cancer	0.00329	0.00461	CcSEcCtD
Isradipine—Urethral disorder—Docetaxel—head and neck cancer	0.00329	0.00461	CcSEcCtD
Isradipine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00324	0.00454	CcSEcCtD
Isradipine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00323	0.00453	CcSEcCtD
Isradipine—Visual impairment—Docetaxel—head and neck cancer	0.00323	0.00453	CcSEcCtD
Isradipine—Tachycardia—Fluorouracil—head and neck cancer	0.00322	0.00451	CcSEcCtD
Isradipine—Vomiting—Vinblastine—head and neck cancer	0.0032	0.00448	CcSEcCtD
Isradipine—Headache—Vinblastine—head and neck cancer	0.00315	0.00441	CcSEcCtD
Isradipine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00314	0.0044	CcSEcCtD
Isradipine—Eye disorder—Docetaxel—head and neck cancer	0.00314	0.00439	CcSEcCtD
Isradipine—Cardiac disorder—Docetaxel—head and neck cancer	0.00311	0.00436	CcSEcCtD
Isradipine—Flushing—Docetaxel—head and neck cancer	0.00311	0.00436	CcSEcCtD
Isradipine—Hypotension—Fluorouracil—head and neck cancer	0.00309	0.00432	CcSEcCtD
Isradipine—Angiopathy—Docetaxel—head and neck cancer	0.00304	0.00426	CcSEcCtD
Isradipine—Dizziness—Hydroxyurea—head and neck cancer	0.00303	0.00425	CcSEcCtD
Isradipine—Immune system disorder—Docetaxel—head and neck cancer	0.00303	0.00424	CcSEcCtD
Isradipine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00302	0.00423	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00301	0.00421	CcSEcCtD
Isradipine—Nausea—Vinblastine—head and neck cancer	0.00299	0.00419	CcSEcCtD
Isradipine—Insomnia—Fluorouracil—head and neck cancer	0.00299	0.00418	CcSEcCtD
Isradipine—Paraesthesia—Fluorouracil—head and neck cancer	0.00297	0.00415	CcSEcCtD
Isradipine—Dyspnoea—Fluorouracil—head and neck cancer	0.00295	0.00412	CcSEcCtD
Isradipine—Mental disorder—Docetaxel—head and neck cancer	0.00294	0.00412	CcSEcCtD
Isradipine—Somnolence—Fluorouracil—head and neck cancer	0.00294	0.00411	CcSEcCtD
Isradipine—Malnutrition—Docetaxel—head and neck cancer	0.00292	0.00409	CcSEcCtD
Isradipine—Vomiting—Hydroxyurea—head and neck cancer	0.00292	0.00409	CcSEcCtD
Isradipine—Dyspepsia—Fluorouracil—head and neck cancer	0.00291	0.00407	CcSEcCtD
Isradipine—Rash—Hydroxyurea—head and neck cancer	0.00289	0.00405	CcSEcCtD
Isradipine—Dermatitis—Hydroxyurea—head and neck cancer	0.00289	0.00405	CcSEcCtD
Isradipine—Headache—Hydroxyurea—head and neck cancer	0.00288	0.00403	CcSEcCtD
Isradipine—Decreased appetite—Fluorouracil—head and neck cancer	0.00287	0.00402	CcSEcCtD
Isradipine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00285	0.00399	CcSEcCtD
Isradipine—Back pain—Docetaxel—head and neck cancer	0.00283	0.00396	CcSEcCtD
Isradipine—Muscle spasms—Docetaxel—head and neck cancer	0.00281	0.00393	CcSEcCtD
Isradipine—Nausea—Hydroxyurea—head and neck cancer	0.00273	0.00382	CcSEcCtD
Isradipine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00272	0.00381	CcSEcCtD
Isradipine—Anaemia—Docetaxel—head and neck cancer	0.0027	0.00378	CcSEcCtD
Isradipine—Urticaria—Fluorouracil—head and neck cancer	0.00262	0.00367	CcSEcCtD
Isradipine—Syncope—Docetaxel—head and neck cancer	0.00262	0.00367	CcSEcCtD
Isradipine—Leukopenia—Docetaxel—head and neck cancer	0.00262	0.00366	CcSEcCtD
Isradipine—Palpitations—Docetaxel—head and neck cancer	0.00258	0.00361	CcSEcCtD
Isradipine—Loss of consciousness—Docetaxel—head and neck cancer	0.00257	0.0036	CcSEcCtD
Isradipine—Cough—Docetaxel—head and neck cancer	0.00255	0.00357	CcSEcCtD
Isradipine—Arthralgia—Docetaxel—head and neck cancer	0.00249	0.00348	CcSEcCtD
Isradipine—Chest pain—Docetaxel—head and neck cancer	0.00249	0.00348	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00247	0.00346	CcSEcCtD
Isradipine—Dry mouth—Docetaxel—head and neck cancer	0.00243	0.00341	CcSEcCtD
Isradipine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00238	0.00334	CcSEcCtD
Isradipine—Oedema—Docetaxel—head and neck cancer	0.00238	0.00334	CcSEcCtD
Isradipine—Shock—Docetaxel—head and neck cancer	0.00235	0.00328	CcSEcCtD
Isradipine—Nervous system disorder—Docetaxel—head and neck cancer	0.00234	0.00327	CcSEcCtD
Isradipine—Pruritus—Fluorouracil—head and neck cancer	0.00234	0.00327	CcSEcCtD
Isradipine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00233	0.00327	CcSEcCtD
Isradipine—Tachycardia—Docetaxel—head and neck cancer	0.00233	0.00326	CcSEcCtD
Isradipine—Skin disorder—Docetaxel—head and neck cancer	0.00232	0.00324	CcSEcCtD
Isradipine—Diarrhoea—Fluorouracil—head and neck cancer	0.00226	0.00316	CcSEcCtD
Isradipine—Hypotension—Docetaxel—head and neck cancer	0.00223	0.00312	CcSEcCtD
Isradipine—Dizziness—Fluorouracil—head and neck cancer	0.00218	0.00306	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00217	0.00304	CcSEcCtD
Isradipine—Insomnia—Docetaxel—head and neck cancer	0.00216	0.00302	CcSEcCtD
Isradipine—Paraesthesia—Docetaxel—head and neck cancer	0.00214	0.003	CcSEcCtD
Isradipine—Dyspnoea—Docetaxel—head and neck cancer	0.00213	0.00298	CcSEcCtD
Isradipine—Somnolence—Docetaxel—head and neck cancer	0.00212	0.00297	CcSEcCtD
Isradipine—Vomiting—Fluorouracil—head and neck cancer	0.0021	0.00294	CcSEcCtD
Isradipine—Dyspepsia—Docetaxel—head and neck cancer	0.0021	0.00294	CcSEcCtD
Isradipine—Rash—Fluorouracil—head and neck cancer	0.00208	0.00292	CcSEcCtD
Isradipine—Dermatitis—Fluorouracil—head and neck cancer	0.00208	0.00291	CcSEcCtD
Isradipine—Decreased appetite—Docetaxel—head and neck cancer	0.00207	0.0029	CcSEcCtD
Isradipine—Headache—Fluorouracil—head and neck cancer	0.00207	0.0029	CcSEcCtD
Isradipine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00206	0.00288	CcSEcCtD
Isradipine—Fatigue—Docetaxel—head and neck cancer	0.00206	0.00288	CcSEcCtD
Isradipine—Constipation—Docetaxel—head and neck cancer	0.00204	0.00285	CcSEcCtD
Isradipine—Feeling abnormal—Docetaxel—head and neck cancer	0.00196	0.00275	CcSEcCtD
Isradipine—Nausea—Fluorouracil—head and neck cancer	0.00196	0.00275	CcSEcCtD
Isradipine—Asthenia—Docetaxel—head and neck cancer	0.00171	0.0024	CcSEcCtD
Isradipine—Pruritus—Docetaxel—head and neck cancer	0.00169	0.00236	CcSEcCtD
Isradipine—Diarrhoea—Docetaxel—head and neck cancer	0.00163	0.00228	CcSEcCtD
Isradipine—Dizziness—Docetaxel—head and neck cancer	0.00158	0.00221	CcSEcCtD
Isradipine—Vomiting—Docetaxel—head and neck cancer	0.00152	0.00212	CcSEcCtD
Isradipine—Rash—Docetaxel—head and neck cancer	0.0015	0.0021	CcSEcCtD
Isradipine—Dermatitis—Docetaxel—head and neck cancer	0.0015	0.0021	CcSEcCtD
Isradipine—Headache—Docetaxel—head and neck cancer	0.00149	0.00209	CcSEcCtD
Isradipine—Nausea—Docetaxel—head and neck cancer	0.00142	0.00198	CcSEcCtD
